AskBio Announces Initiation of Phase 2 GenePHIT Trial in Congestive Heart Failure
GenePHIT, which is now enrolling, will study AB-1002 in adults with NYHA Class III Heart Failure and non-ischemic…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Jan 24
GenePHIT, which is now enrolling, will study AB-1002 in adults with NYHA Class III Heart Failure and non-ischemic…
05 Jan 24
The latest partnership, which is the second research strategic collaboration between Boehringer Ingelheim and 3T, will leverage Boehringer…
05 Jan 24
The partnership capitalises on MOMA's KnowledgeBase platform to pinpoint and advance novel precision oncology targets characterised by high…
05 Jan 24
The partnership intends to combine Umoja's proprietary VivoVec gene delivery platform with AbbVie's expertise in oncology to develop…
05 Jan 24
Paragon Healthcare, headquartered in Plano, Texas, offers infusion services to patients via its omnichannel model of ambulatory infusion…
05 Jan 24
Under the agreement, Rhythm will pay $20m in Rhythm shares, $40m in cash to LG Chem at closing,…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
05 Jan 24
The latest issue of the Seafood Processing Standard (SPS), which adopted a new format from the previous issue…
05 Jan 24
The new four-story 20,000 m² facility will feature mammalian cell culture, messenger RNA and cell therapy services and…
05 Jan 24
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a strategic plan to step up investments over the…
05 Jan 24
IFE Manufacturing, IFE, The Pub Show, HRC and International Salon Culinaire have joined forces under a new over-arching…